The burgeoning landscape of novel treatments for weight management has seen the rise of both retatrutide and tirzepatide, both dual approach agonists targeting the GLP-1 and GIP receptors. While sharing a similar https://arranuvdk198629.lotrlegendswiki.com/1989110/retatrutide_vs_tirzepatide_a_comparative_analysis